Market Overview

5 Biggest Price Target Changes For Friday

Related ABT
The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding
The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut
Gritstone Oncology Prepares Final Terms For IPO (Seeking Alpha)
Related V
Dan Nathan Sees Unusual Options Activity In Visa
US-Mexico Trade Deal Seems to Continue to Boost Stock Market Sentiment
  • Deutsche Bank raised Abbott Laboratories (NYSE: ABT) price target from $49 to $56. Abbott shares closed at $50.85 on Thursday.
  • Instinet boosted the price target on Visa Inc (NYSE: V) from $105 to $120. Visa shares closed at $98.11 on Thursday.
  • Argus lowered the price target for International Business Machines Corp. (NYSE: IBM) from $192 to $175. IBM shares closed at $147.66 on Thursday.
  • Stifel raised Cintas Corporation (NASDAQ: CTAS) price target from $123 to $136. Cintas shares closed at $126.78 on Thursday.
  • Jefferies boosted the price target for Microsoft Corporation (NASDAQ: MSFT) from $45 to $49. Microsoft shares closed at $74.22 on Thursday.

Latest Ratings for ABT

Jul 2018Stifel NicolausMaintainsBuyBuy
Jun 2018BernsteinInitiates Coverage OnOutperform
Apr 2018CitigroupMaintainsNeutralNeutral

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: Price Target ChangesPrice Target Analyst Ratings


Related Articles (CTAS + ABT)

View Comments and Join the Discussion!

Exclusive: DelMar Pharma CEO Sheds Light On Glioblastoma, And How Its Drug Could Help Sen. John McCain

Johnson & Johnson Shares Might Break Lower Before They Break Out